{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:06:17Z","timestamp":1776254777988,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12891-w","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:33:45Z","timestamp":1773048825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C and HIV co-infection, viral load, and liver enzyme profiles among intravenous and non-intravenous drug users in Jorhat, Assam: a comparative analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Pinkee","family":"Phukon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbi","family":"Gogoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angshurekha","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima Kumari","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purnima","family":"Barua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"12891_CR1","unstructured":"World Health Organisation, Hepatitis C. 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"issue":"6","key":"12891_CR2","doi-asserted-by":"publisher","first-page":"e1254","DOI":"10.1093\/infdis\/jiae253","volume":"230","author":"JL Mbisa","year":"2024","unstructured":"Mbisa JL, Lapp Z, Bibby DF, Phillips LT, Manso CF, Packer S, Simmons R, Harris K, Mohan J, Chinnappan L, Leitner T. Identification of 2 novel subtypes of hepatitis C virus genotype 8 and a potential new genotype successfully treated with direct acting antivirals. J Infec Dis. 2024;230(6):e1254\u201362.","journal-title":"J Infec Dis"},{"key":"12891_CR3","doi-asserted-by":"crossref","unstructured":"Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. In Seminars in liver disease. 2000;0017\u20130036.","DOI":"10.1055\/s-2000-9505"},{"issue":"3","key":"12891_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4103\/0971-5916.166596","volume":"142","author":"D Basu","year":"2015","unstructured":"Basu D, Sharma AK, Gupta S, Nebhinani N, Kumar V. Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in Northern India. Indian J Med Res. 2015;142(3):311\u20136.","journal-title":"Indian J Med Res"},{"issue":"5","key":"12891_CR5","first-page":"640","volume":"128","author":"PK Chelleng","year":"2008","unstructured":"Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J. Risk of hepatitis C infection among injection drug users in Mizoram, India. Indian J Med Res. 2008;128(5):640\u20136.","journal-title":"Indian J Med Res"},{"issue":"6","key":"12891_CR6","doi-asserted-by":"publisher","first-page":"100522","DOI":"10.1016\/j.clinme.2025.100522","volume":"25","author":"HZ Farooq","year":"2025","unstructured":"Farooq HZ, Foster GR, Hepatitis C. Current treatments, emerging therapies and tackling health inequities on the path to global elimination. Clin Med. 2025;25(6):100522.","journal-title":"Clin Med"},{"issue":"7","key":"12891_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/v16071115","volume":"16","author":"T Stroffolini","year":"2024","unstructured":"Stroffolini T, Stroffolini G. Prevalence and modes of transmission of hepatitis C virus infection: A historical worldwide review. Viruses. 2024;16(7):1115.","journal-title":"Viruses"},{"key":"12891_CR8","doi-asserted-by":"publisher","first-page":"104387","DOI":"10.1016\/j.drugpo.2024.104387","volume":"144","author":"J Chapin-Bardales","year":"2025","unstructured":"Chapin-Bardales J, Asher A, Broz D, Teshale E, Mixson-Hayden T, Poe A, Handanagic S, Blanco C, Wejnert C, NHBS HCV Study Group. Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 US cities\u2014National HIV behavioral Surveillance, 2018. Int J Drug Policy. 2025;144:104387.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"12891_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2025.04.028","volume":"83","author":"CA Fulgenzi","year":"2025","unstructured":"Fulgenzi CA, Dalla Pria A, Leone AG, Celsa C, Cabibbo G, Scheiner B, Pinter M, D\u2019Alessio A, Zhao Y, Brau N, Bower M. Hepatocellular carcinoma in people living with HIV. J Hepatol. 2025;83(4):971\u201381.","journal-title":"J Hepatol"},{"issue":"48","key":"12891_CR10","doi-asserted-by":"publisher","first-page":"e31688","DOI":"10.1097\/MD.0000000000031688","volume":"101","author":"S Aridoss","year":"2022","unstructured":"Aridoss S, David JK, Jaganathasamy N, Mathiyazhakan M, Balasubramanian G, Natesan M, VM P, Kumar P, Rajan S, Arumugam E. Spatial heterogeneity of risk factors associated with HIV prevalence among men who inject drugs in india: an analysis of the data from the integrated bio-behavioral surveillance, India. Medicine. 2022;101(48):e31688.","journal-title":"Medicine"},{"issue":"1","key":"12891_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12889-015-2003-z","volume":"15","author":"L Ray Saraswati","year":"2015","unstructured":"Ray Saraswati L, Sarna A, Sebastian MP, Sharma V, Madan I, Thior I, Pulerwitz J, Tun W. HIV, hepatitis B and C among people who inject drugs: high prevalence of HIV and hepatitis C RNA positive infections observed in Delhi, India. BMC Public Health. 2015;15(1):726.","journal-title":"BMC Public Health"},{"issue":"1\u20132","key":"12891_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1386-6532(00)00151-7","volume":"20","author":"A Berger","year":"2001","unstructured":"Berger A, Preiser W, Doerr HW. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol. 2001;20(1\u20132):23\u201330.","journal-title":"J Clin Virol"},{"key":"12891_CR13","doi-asserted-by":"crossref","unstructured":"Ahmad F, Junaid K, Mustafa A. Relationship of liver enzymes with viral load of hepatitis C in HCV infected patients by data analytics. Age. 2018;5:18.","DOI":"10.14569\/IJACSA.2018.091170"},{"issue":"16","key":"12891_CR14","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3748\/wjg.v10.i16.2409","volume":"10","author":"BS Anand","year":"2004","unstructured":"Anand BS, Velez M. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease. World J Gastroenterol. 2004;10(16):2409.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"12891_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/v17081069","volume":"17","author":"D Toma","year":"2025","unstructured":"Toma D, Anghel L, Patra\u0219 D, Ciubar\u0103 A. Hepatitis C virus: epidemiological challenges and global strategies for elimination. Viruses. 2025;17(8):1069.","journal-title":"Viruses"},{"issue":"4","key":"12891_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/jvh.13646","volume":"29","author":"AJ Stockdale","year":"2022","unstructured":"Stockdale AJ, Kreuels B, Shawa IT, Meiring JE, Thindwa D, Silungwe NM, Chetcuti K, Joekes E, Mbewe M, Mbale B, Patel P. A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission. J Viral Hepatitis. 2022;29(4):252\u201362.","journal-title":"J Viral Hepatitis"},{"issue":"3","key":"12891_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3138\/canlivj.2019-0023","volume":"3","author":"F Zietara","year":"2020","unstructured":"Zietara F, Crotty P, Houghton M, Tyrrell L, Coffin CS, Macphail G. Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs. Can Liver J. 2020;3(3):276\u201385.","journal-title":"Can Liver J"},{"issue":"12","key":"12891_CR18","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K, Lynskey M. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192\u2013207.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"12891_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12954-024-00939-6","volume":"21","author":"LR Marks","year":"2024","unstructured":"Marks LR, Durkin MJ, Ayres K, Ellis M. Drug preparation, injection-related infections, and harm reduction practices among a National sample of individuals entering treatment for opioid use disorder. Harm Reduct J. 2024;21(1):16.","journal-title":"Harm Reduct J"},{"issue":"1","key":"12891_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ajp.2012.08.008","volume":"6","author":"D Basu","year":"2013","unstructured":"Basu D, Kumar V, Sharma AK, Barnwal PK, Mattoo SK. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in Northern india: comparison with non-injecting drug users. Asian J Psychiatr. 2013;6(1):52\u20135.","journal-title":"Asian J Psychiatr"},{"key":"12891_CR21","doi-asserted-by":"crossref","unstructured":"Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y. Impact of a treatment as prevention strategy on hepatitis C virus transmission and on morbidity in people who inject drugs. arXiv preprint arXiv:1506.02987. 2015.","DOI":"10.1002\/hep.28227"},{"issue":"1","key":"12891_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1186\/s12879-021-06521-w","volume":"21","author":"K Kase","year":"2021","unstructured":"Kase K, Avi R, Toompere K, Rajasaar H, Pauskar M, Soodla P, J\u00f5geda EL, Zilmer K, Lutsar I, Huik K. Dynamics of hepatitis C epidemic among people living with HIV in Estonia based on Estonian HIV cohort study. BMC Infect Dis. 2021;21(1):792.","journal-title":"BMC Infect Dis"},{"key":"12891_CR23","unstructured":"Khalsa JH, Vocci F. Management of human immunodeficiency virus and hepatitis c virus co-infections in drug abusers. Manage Med Disorders Assoc Drug Abuse Addict. Nova Publishers. 2007:161."},{"issue":"6","key":"12891_CR24","first-page":"706","volume":"132","author":"SH Mehta","year":"2010","unstructured":"Mehta SH, Vogt SL, Srikrishnan AK, Vasudevan CK, Murugavel KG, Saravanan S, Anand S, Kumar MS, Ray SC, Celentano DD, Solomon S. Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India. IJMR. 2010;132(6):706\u201314.","journal-title":"IJMR"},{"issue":"4","key":"12891_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11904-018-0406-z","volume":"15","author":"P Mateu-Gelabert","year":"2018","unstructured":"Mateu-Gelabert P, Guarino H, Quinn K, Meylakhs P, Campos S, Meylakhs A, Berbesi D, Toro-Tob\u00f3n D, Goodbody E, Ompad DC, Friedman SR. Young drug users: a vulnerable population and an underutilized resource in HIV\/HCV prevention. Curr HIV\/AIDS Rep. 2018;15(4):324\u201335.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"12891_CR26","doi-asserted-by":"publisher","first-page":"103872","DOI":"10.1016\/j.drugpo.2022.103872","volume":"109","author":"N Palmateer","year":"2022","unstructured":"Palmateer N, Hamill V, Bergenstrom A, Bloomfield H, Gordon L, Stone J, Fraser H, Seyler T, Duan Y, Tran R, Trayner K. Interventions to prevent HIV and hepatitis C among people who inject drugs: latest evidence of effectiveness from a systematic review (2011 to 2020). Int J Drug Policy. 2022;109:103872.","journal-title":"Int J Drug Policy"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12891-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:20:28Z","timestamp":1776252028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12891-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12891"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12891-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the Institutional Ethical Committee of Jorhat Medical College & Hospital, Jorhat, Assam (under Society for Medical Education, Jorhat) in accordance with the Declaration of Helsinki with letter no. SMEJ\/JMCH\/MEU\/841\/Pt-2\/2011\/957, Dated February 16th, 2023. The samples were collected after taking written informed consent from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"763"}}